bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the target of a large increase in short interest in September. As of September 30th, there was short interest totaling 1,934 shares, an increase of 334.6% from the September 15th total of 445 shares. Based on an average trading volume of 2,441 shares, the days-to-cover ratio is presently 0.8 days.
bioAffinity Technologies Price Performance
BIAFW stock traded down $0.05 during mid-day trading on Friday, reaching $0.35. 270 shares of the company traded hands, compared to its average volume of 5,096. bioAffinity Technologies has a fifty-two week low of $0.05 and a fifty-two week high of $0.98. The firm’s 50 day moving average price is $0.25 and its 200 day moving average price is $0.23.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc is a biotechnology company focused on developing diagnostic and therapeutic products for cancer and other serious diseases. The company’s platform uses proprietary porphyrin-based compounds designed to selectively interact with cancer cells and support their detection or treatment.
Its lead diagnostic product, CyPath Lung, is a noninvasive urine test intended to aid in the detection of lung cancer. The test uses a porphyrin compound delivered in nanoparticles and analyzed through fluorescence-based methods.
See Also
- Five stocks we like better than bioAffinity Technologies
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
